Overview

A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers

Status:
Completed

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

This is a single-center, two-period, randomized, open-label, crossover pharmacokinetic (PK) study in healthy adult volunteers to evaluate dose proportionality of diazepam nasal spray using two dose levels

Phase:

Phase 1

Details

Lead Sponsor:

Acorda Therapeutics

Treatments:

Diazepam